[1]
“DESIGN, SYNTHESIS AND ANTICANCER ACTIVITY OF STRUCTURALLY MODIFIED 1, 3, 4-OXADIAZOLE INCORPORATED 2H-CHROMENE DERIVATIVES AS ANTICANCER AGENTS ”, Int. Res. J. Pharm., vol. 10, no. 10, pp. 87–92, Oct. 2019, Accessed: Jun. 15, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/725